Search results
Professor Peter Clark is a consultant medical oncologist who has practised since 1989. He was Medical Director of his Hospital Trust from 1994-2000, Director of the Merseyside and Cheshire Cancer Research Network 2001-2009 and Director of his Trust's Research and Development 2004-2009.
- 127
- 149
- NHS England
- The Cancer Drugs Fund: A Brief History
- Existing Treatments Reviewed Again
- Record of Success
The Fund was introduced in 2011 by the then coalition government. And until 2016, it was used to pay for drugs that NICE had rejected or hadn’t reviewed, because there wasn’t strong evidence that they were effective enough to justify their cost. This meant many patients could be prescribed drugs that wouldn’t otherwise have been available, which wa...
As part of the 2016 redesign, NICE also agreed to review all 33 treatments options that were previously being paid for by the old Fund and had been licensed by the European Medicines Agency (meaning the drugs are officially certified as safe and effective to treat a specific cancer type). The reviews offered a shot at regular NHS funding for these ...
New managed access drugs have been entering the Fundat a rate of roughly one per month since mid-2017. And while the CDF only covers England, drugs being put into the Fund will also benefit patients in Wales and Northern Ireland. For patients in Wales, all managed access drugs are now covered by the New Treatment Fund. The Northern Ireland Departme...
Oct 17, 2023 · NHS England’s Cancer Drug’s Fund Lead, Professor Peter Clark, said: “The approval of this drug is great news for people living with an advanced and aggressive form of blood cancer, who are set to benefit from this new treatment.
Peter Frederick Clarke, FBA (born 21 July 1942) is an English historian. Education. ... professor of modern British history from 1991 to 2004. ...
Apr 11, 2024 · Professor Peter Clark, lead of NHS England’s CDF, added: “It’s great news that this potentially curative drug is now being rolled out for routine use in the NHS for treating children and ...
Mar 5, 2024 · Professor Peter Clark, NHS England’s Cancer Drugs Fund (CDF) lead, said: “The rollout of this drug as a first-line treatment on the NHS is great news for patients living with this type of womb ...
Apr 21, 2022 · Peter Clark, MD. Professor Clark is a medical oncologist and practised in Liverpool for over 28 years. His roles have included being Medical Director of his Trust (1993-2000), Director of the Mersey & Cheshire Cancer Research Network (2001-2008), leading his specialty of medical oncology nationally (2000-2006), serving on the NICE Technology ...
